Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study

View ORCID ProfileSebastian Weis, André Scherag, Michael Baier, Michael Kiehntopf, View ORCID ProfileThomas Kamradt, Steffi Kolanos, Juliane Ankert, Stefan Glöckner, View ORCID ProfileOliwia Makarewicz, View ORCID ProfileStefan Hagel, Christina Bahrs, Aurelia Kimmig, Hans Proquitté, Joel Guerra, Bettina Löffler, View ORCID ProfileMathias W. Pletz, CoNAN study group.
doi: https://doi.org/10.1101/2020.07.15.20154112
Sebastian Weis
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
2Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany
3Department of Anesthesiology and Intensive Care, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Weis
André Scherag
4Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Baier
5Institute of Medical Microbiology, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Kiehntopf
6Institute of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Kamradt
7Institute of Immunology, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Kamradt
Steffi Kolanos
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliane Ankert
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Glöckner
5Institute of Medical Microbiology, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliwia Makarewicz
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oliwia Makarewicz
Stefan Hagel
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefan Hagel
Christina Bahrs
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
8Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurelia Kimmig
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Proquitté
9Children’s Hospital, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Guerra
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
2Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bettina Löffler
5Institute of Medical Microbiology, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathias W. Pletz
1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mathias W. Pletz
  • For correspondence: Mathias.Pletz@med.uni-jena.de Sebastian.Weis@med.uni-jena.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Due to the substantial proportion of asymptomatic and mild courses many SARS-CoV-2 infections remain unreported. Therefore, assessment of seroprevalence may detect the real burden of disease. We aimed at determining and characterizing the rate of SARS-CoV-2 infections and the resulting immunity in a defined population.

Methods CoNAN is a population-based cohort study in the previously quarantined community Neustadt-am-Rennsteig, Germany six weeks after a SARS-CoV-2 outbreak with 49 cases identified by PCR screening of all 883 inhabitants. The primary objective of the study was to assess SARS-CoV-2 antibody seroconversion rate using six different IgG detecting immunoassays. Secondary objectives of the study were: i.) to determine the rate of seroconversion in children; ii.) to determine potential risk factors for symptomatic vs. asymptomatic Covid19 courses; iii.) to investigate the rate of virus persistence.

Findings We enrolled 626 participants (71% of the community population). All actual SARS-CoV-2 PCR tests were negative; while a total of 8·4% (52 of 620 tested) had antibodies against SARS-CoV-2 in at least two independent tests. Twenty of the antibody positive participants had previously a positive SARS-CoV-2 PCR. On the contrary, of those 38 participants with SARS-CoV-2 infection, only 20 (52·6%) were antibody positive.

Interpretation Several antibody tests conducted six weeks after an outbreak of SARS-CoV-2 did not detect all previously PCR-positive tested individuals. Cautious evaluation of antibody testing strategies to assess immunity against the infection is warranted.

Funding CoNAN was funded by the Thuringian Ministry for Economic Affairs, Science and Digital Society (TMWWDG).

Competing Interest Statement

SW received speakers fees from MSD and Infectopharm. SH received speakers fees from Pfizer, MSD and Astra Zeneca. TK speakers fees from Roche MP has participated in international advisory boards from Pfizer, Novartis, Basilea and Cubist and received speakers fees from the same companies. CB has participated in advisory boards from GSK and received speakers fees from Pfizer. All other authors do not report any conflict of interest

Clinical Trial

DRKS00022416 (submitted)

Funding Statement

CoNAN was funded by the Thuringian Ministry for Economic Affairs, Science and Digital Society (TMWWDG).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted according to the current version of the Declaration of Helsinki and has been approved by the institutional ethics committees of the Jena University Hospital and the respective data protection commissioner (approval number 2020-1776) and the ethics committee of the Thuringian chamber of physicians.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Study Group: Technische Universität Ilmenau, Ilmenau, Germany: Thomas Hotz

  • Local Cooperation partners: Petra Enders, Renate Koch, Steffen Mai, Matthias Ullrich

  • Thuringian state office for consumer protection, Bad Langensalza, Germany: Dagmar Rimek.

  • Institute of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena, Germany: Cora Richert, Cornelius Eibner, Bettina Meinung, Kay Stötzer, Julia Köhler.

  • Children’s Hospital, JUH, Jena, Germany: Hans Cipowicz, Christine Pinkwart

  • Department of Anesthesiology and Intensive Care Medicine, JUH, Jena, Germany: Michael Bauer, Petra Dickmann, Annika Licht, Juliane Scholz, Wibke Wetzker.

  • Institute for Infectious Disease and Infection Control, JUH, Jena, Germany: Anita Hartung, Daniel Weiss, Lara Thieme, Gabi Hanf, Clara Schnizer, Jasmin Müller, Jennifer Kosenkow, Franziska Röstel

  • Institute of Immunology, JUH, Jena, Germany: Nico Andreas, Raphaela Marquardt

  • Institute of Medical Microbiology, JUH, Jena, Germany: Stefanie Deinhardt-Emmer, Sebastian Kuhn

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request after publication of the manuscript.

  • ABBREVIATIONS

    CI
    confidence interval
    GEE
    generalized estimation equations
    MERS-CoV
    Middle East respiratory syndrome-related coronavirus
    OR
    odds ratio
    SARS-CoV
    severe acute respiratory syndrome-related coronavirus
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 17, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study
    Sebastian Weis, André Scherag, Michael Baier, Michael Kiehntopf, Thomas Kamradt, Steffi Kolanos, Juliane Ankert, Stefan Glöckner, Oliwia Makarewicz, Stefan Hagel, Christina Bahrs, Aurelia Kimmig, Hans Proquitté, Joel Guerra, Bettina Löffler, Mathias W. Pletz, CoNAN study group.
    medRxiv 2020.07.15.20154112; doi: https://doi.org/10.1101/2020.07.15.20154112
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study
    Sebastian Weis, André Scherag, Michael Baier, Michael Kiehntopf, Thomas Kamradt, Steffi Kolanos, Juliane Ankert, Stefan Glöckner, Oliwia Makarewicz, Stefan Hagel, Christina Bahrs, Aurelia Kimmig, Hans Proquitté, Joel Guerra, Bettina Löffler, Mathias W. Pletz, CoNAN study group.
    medRxiv 2020.07.15.20154112; doi: https://doi.org/10.1101/2020.07.15.20154112

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1095)
    • Dentistry and Oral Medicine (196)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
    • Epidemiology (9766)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2308)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1557)
    • Health Policy (734)
    • Health Systems and Quality Improvement (603)
    • Hematology (236)
    • HIV/AIDS (503)
    • Infectious Diseases (except HIV/AIDS) (11639)
    • Intensive Care and Critical Care Medicine (617)
    • Medical Education (237)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2142)
    • Nursing (134)
    • Nutrition (336)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1175)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (146)
    • Palliative Medicine (50)
    • Pathology (311)
    • Pediatrics (695)
    • Pharmacology and Therapeutics (300)
    • Primary Care Research (267)
    • Psychiatry and Clinical Psychology (2180)
    • Public and Global Health (4654)
    • Radiology and Imaging (776)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (210)
    • Surgery (251)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)